| Primary reference | Discovery of 3-Cyano-N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1H-pyrrolo [2,3-b]pyridin-5-yl)benzamide. A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 (RORC2) Inverse Agonist., Schnute ME, Wennerstal M, Alley J, Bengtsson M, Blinn JR, Bolten CW, Braden T, Bonn T, Carlsson B, Caspers NL, Chen MZ, Choi C, Collis LP, Crouse K, F Auml Rneg Aring Rdh M, Fennell KF, Fish S, Flick A, Goos-Nilsson A, Gullberg H, Harris PK, Heasley SE, Hegen M, Hromockyj AE, Hu X, Husman B, Janosik T, Jones P, Kaila N, Kallin E, Kauppi B, Kiefer JR, Knafels JD, Koehler K, Kruger L, Kurumbail RG, Kyne RE Jr, Li W, Lofstedt J, Long SA, Menard CA, Mente S, Messing D, Meyers MJ, Napierata L, Noteberg D, Nuhant P, Pelc MJ, Prinsen MJ, Rhonnstad P, Backstrom-Rydin E, Sandberg J, Sandstrom M, Shah F, Sjoberg M, Sundell A, Taylor AP, Thorarensen A, Trujillo JI, Trzupek JD, Unwalla R, Vajdos FF, Weinberg RA, Wood DC, Xing L, Zamaratski E, Zapf CW, Zhao Y, Wilhelmsson A, Berstein G, J Med Chem. 2018 Aug 21. doi: 10.1021/acs.jmedchem.8b00392. PMID:30130103 |
